E. Odenwald

2.0k citations

17 papers · 1.1k indexed · h-index 11

Impact in

Hematology top 2%
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation
- Chronic Myeloid Leukemia Treatments
Public Health, Environmental and Occupational Health top 2%
- Acute Lymphoblastic Leukemia research

Papers in

Hematology 5
- Acute Myeloid Leukemia Research 3
- Chronic Myeloid Leukemia Treatments 3
Public Health, Environmental and Occupational Health 12
- Acute Lymphoblastic Leukemia research 12

Co-authors: Alfred Reiter G. Henze Martin Schrappe H. Riehm Jochen Harbott M Zimmermann WD Ludwig Helmut Gadner
Journals: Blood (2 papers)Annals of Hematology (1 paper)Journal of Pediatric Hematology/Oncology (1 paper)Recent results in cancer research (1 paper)Leukemia (1 paper)
Partner nations: Germany Austria Switzerland

In The Last Decade

E. Odenwald

17 papers receiving 1.0k citations

Peers

Countries citing papers authored by E. Odenwald

Since Specialization

Citations

This map shows the geographic impact of E. Odenwald's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Odenwald with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Odenwald more than expected).

Fields of papers citing papers by E. Odenwald

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Odenwald. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Odenwald. The network helps show where E. Odenwald may publish in the future.

Co-authorship network

The 25 scholars most cited alongside E. Odenwald, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with E. Odenwald Line = papers co-authored together E. Odenwald links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

#	Work
1	Prediction of Outcome by Early Response in Childhood Acute Lymphoblastic Leukemia Klinische Pädiatrie ·Anja Möricke, Melchior Lauten, Rita Beier, E. Odenwald, Martin Stanulla, M Zimmermann, Andishe Attarbaschi, Felix Niggli, Martin Schrappe	2013	10
2	Prediction of outcome by early bone marrow response in childhood acute lymphoblastic leukemia treated in the ALL-BFM 95 trial: differential effects in precursor B-cell and T-cell leukemia Haematologica ·Melchior Lauten, Anja Möricke, Rita Beier, M. Zimmermann, M. Stanulla, Barbara Meissner, E. Odenwald, Andishe Attarbaschi, C. Niemeyer, Felix Niggli, H. Riehm, Martin Schrappe	2012	49
3	Prognostic Impact of Age in Children and Adolescents with Acute Lymphoblastic Leukemia: Data from the Trials ALL-BFM 86, 90, and 95 Klinische Pädiatrie ·Anja Möricke, M Zimmermann, Alfred Reiter, H. Gadner, E. Odenwald, Jochen Harbott, Wolfgang Ludwig, H. Riehm, Martin Schrappe	2005	80
4	Long-term results of four consecutive trials in childhood ALL performed by the ALL-BFM study group from 1981 to 1995 Leukemia ·Martin Schrappe, Alfred Reiter, M Zimmermann, Jochen Harbott, WD Ludwig, G. Henze, Helmut Gadner, E. Odenwald, H. Riehm	2000	396
5	Therapiestudie NHL-BFM 90 zur Behandlung maligner Non-Hodgkin-Lymphome bei Kindern und Jugendlichen - Teil 1: Klassifikation und Einteilung in strategische Therapiegruppen Klinische Pädiatrie ·Alfred Reiter, Markus Tiemann, W.-D. Ludwig, H.-H. Wacker, Elif Yakisan, Martin Schrappe, Dietrich Henzler, Karl W. Sykora, Alan E. Brandt, E. Odenwald, H. Riehm, Reza Parwaresch	1994	17
6	Konzeption und Zwischenergebnis der Therapiestudie ALL-BFM 90 zur Behandlung der akuten lymphoblastischen Leukämie bei Kindern und Jugendlichen: Die Bedeutung des initialen Therapieansprechens in Blut und Knochenmark Klinische Pädiatrie ·Martin Schrappe, Alfred Reiter, S. Sauter, Wolfgang Ludwig, B. Wörmann, Jochen Harbott, Christine Bender‐Götze, W Dörffel, R. Dopfer, E. Frey, Jin Deug Heo, G. Henze, Jörn‐Sven Kühl, Ruth Richter, J. Ritter, J. Treuner, F Zintl, E. Odenwald, Karl Welte, Lv Xuefeng	1994	83
7	Incidence and Prognostic Significance of Immunophenotypic Subgroups in Childhood Acute Lymphoblastic Leukemia: Experience of the BFM Study 86 Recent results in cancer research ·W. D. Ludwig, Jochen Harbott, CR Bartram, Lizeth Cordova-Galarza, Christian Sperling, E. Löbel, Luigi Gaggero, Michael Notter, E. Odenwald, 蒙道杨 Meng Daoyang, E. Thiel, H. Riehm	1993	38
8	Inzidenz, klinische Merkmale und prognostische Bedeutung immunologischer Subtypen der akuten lymphoblastischen Leukämie (ALL) im Kindesalter: Erfahrungen der Therapiestudien ALL-BFM 83 und 86 Klinische Pädiatrie ·W. D. Ludwig, E. Löbel, Christian Sperling, Lizeth Cordova-Galarza, J. Ritter, Alfred Reiter, E. Odenwald, S. Sauter, H. Riehm	1990	13
9	Differential effects of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor in children with severe congenital neutropenia Blood ·Karl Welte, C Zeidler, Alfred Reiter, Walther Müller, E. Odenwald, L Souza, H. Riehm	1990	215
10	Differential effects of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor in children with severe congenital neutropenia Blood ·Karl Welte, Cornelia Zeidler, Alfred Reiter, Walther Müller, E. Odenwald, L Souza, M.J. Campion	1990	9
11	Clinicopathological Features and Prognostic Implications of Immunophenotypic Subgroups in Childhood ALL: Experience of the BFM-ALL Study 83 Hämatologie und Bluttransfusion ·W. D. Ludwig, Luigi Gaggero, E. Löbel, Lizeth Cordova-Galarza, Uri Kartoun, George Gassner, E. Odenwald, Jan Hofmann, H. Riehm	1989	6
12	Myelodysplastic Syndromes in Childhood Journal of Pediatric Hematology/Oncology ·Ursula Creutzig, A Cantù-Rajnoldi, Zhu Xun, Lorenza Romitti, E. Odenwald, Valentino Conter, H. Riehm, 贾学义	1987	57
13	Kindliche B-Zell-Lymphome und -Leukämien Oncology Research and Treatment ·St. Müller-Weihrich, G. Henze, H. Langermann, E. Odenwald, H. Riehm	1984	5
14	Use of monoclonal antibodies as a diagnostic tool in human leukemia Annals of Hematology ·F. Herrmann, Lizeth Cordova-Galarza, E. Odenwald, Wolfgang Ludwig	1983	24
15	THE BERLIN CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA THERAPY STUDY, 1970-1976 H. Riehm, H. Gadner, G. Henze, Himanshu Dwivedi, E. Odenwald	1980	81
16	[Differential diagnosis of acute leukemia in childhood by means of electronic cell-volume determination]. PubMed ·Criswell Tafadzwa Gandi, Robyn P. Thom, E. Odenwald, H. Riehm	1977	2
17	[Counting of platelets by means of an electronic counter in the hematologic service laboratory]. PubMed ·Helmut Gadner, E. Odenwald, Zhang Jian-yu, Syed Fazl-i-Hadi	1974	1

About E. Odenwald

E. Odenwald is a scholar working on Hematology, Public Health, Environmental and Occupational Health, Genetics, Pediatrics, Perinatology and Child Health and Immunology, having authored 17 papers that have together received 1.1k indexed citations. Recurring topics across this work include Acute Lymphoblastic Leukemia research (12 papers), Acute Myeloid Leukemia Research (3 papers), Chronic Lymphocytic Leukemia Research (3 papers), Childhood Cancer Survivors' Quality of Life (3 papers), Immunodeficiency and Autoimmune Disorders (3 papers), Chronic Myeloid Leukemia Treatments (3 papers), Cancer therapeutics and mechanisms (2 papers) and Neutropenia and Cancer Infections (2 papers). The work is most often cited by research in Hematology (483 citations), Public Health, Environmental and Occupational Health (681 citations), Pediatrics, Perinatology and Child Health (408 citations), Oncology (276 citations) and Immunology (170 citations). E. Odenwald has collaborated with scholars based in Germany, Austria and Switzerland. Frequent co-authors include Alfred Reiter, G. Henze, Martin Schrappe, H. Riehm, Jochen Harbott, H. Riehm, M Zimmermann, WD Ludwig, Helmut Gadner and Walther Müller. Their work appears in journals such as Blood, Annals of Hematology, Journal of Pediatric Hematology/Oncology, Recent results in cancer research and Leukemia.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact